Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
Top Cited Papers
Open Access
- 20 October 2020
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 324 (15), 1565-1567
- https://doi.org/10.1001/jama.2020.17052
Abstract
An abnormally strong proinflammatory response known as “cytokine storm” may play an important role in the pathophysiology of coronavirus disease 2019 (COVID-19), although cytokine storm remains ill defined.1 Sinha and colleagues2 reported that although IL-6 levels are elevated in severe COVID-19, they are lower than levels usually observed in (non–COVID-19) acute respiratory distress syndrome (ARDS). However, this comparison is limited by the use of different assays, which are not well standardized.3 We compared cytokine levels in critically ill patients with COVID-19 vs levels in patients with other critical illnesses.This publication has 7 references indexed in Scilit:
- Is a “Cytokine Storm” Relevant to COVID-19?JAMA Internal Medicine, 2020
- Norepinephrine Contributes to Enterocyte Damage in Septic Shock Patients: A Prospective Cohort StudyShock, 2018
- Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patientsIntensive Care Medicine, 2016
- The Involvement of Danger-Associated Molecular Patterns in the Development of Immunoparalysis in Cardiac Arrest PatientsCritical Care Medicine, 2015
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012
- Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturersCytometry Part B: Clinical Cytometry, 2004
- CytometryCytometry, 2000